Risperdal and Vasculitis - a phase IV clinical study of FDA data

Summary:

Vasculitis is reported as a side effect among people who take Risperdal (risperidone), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Tegretol, and have Agitation.

The phase IV clinical study analyzes which people have Vasculitis when taking Risperdal. It is created by eHealthMe based on reports of 126,253 people who have side effects when taking Risperdal from the FDA, and is updated regularly.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 968 drugs and 1,214 conditions by eHealthMe. Check the latest studies of Vasculitis.

On Jul, 05, 2026

126,253 people reported to have side effects when taking Risperdal.
Among them, 28 people (0.02%) have Vasculitis.

Among these 28 people:

How long have people been on Risperdal when they have Vasculitis? *

What is the gender of people who have Vasculitis when taking Risperdal? *

female: 39.29 %
male: 60.71 %

What is the age of people who have Vasculitis when taking Risperdal? *

What are other drugs people take besides Risperdal? *

Lorazepam: 4 people, 14.29%
Tegretol: 4 people, 14.29%
Mirtazapine: 3 people, 10.71%
Prilosec: 2 people, 7.14%
Zoloft: 2 people, 7.14%
Amoxicillin: 2 people, 7.14%
Prednisone: 2 people, 7.14%
Seroquel: 2 people, 7.14%
Paxil: 2 people, 7.14%
Bupropion Hydrochloride: 2 people, 7.14%

What are other side effects people have besides Vasculitis? *

Rashes (redness): 4 people, 14.29%
Urinary Tract Infection: 3 people, 10.71%
Abdominal Pain Upper: 3 people, 10.71%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 2 people, 7.14%
Erysipelas (bacterial skin infection): 2 people, 7.14%
Cerebral Oedema (swelling of brain): 2 people, 7.14%
Chest Pain: 2 people, 7.14%
Pneumonia: 2 people, 7.14%
Cardiac Disorder: 2 people, 7.14%
C-Reactive Protein Increased: 2 people, 7.14%

What are the existing conditions these people have? *

Stress And Anxiety: 2 people, 7.14%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 7.14%
Psychotic Disorder: 2 people, 7.14%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 2 people, 7.14%
Depression: 2 people, 7.14%
Agitation (state of anxiety or nervous excitement): 2 people, 7.14%
Urinary Tract Infection: 1 person, 3.57%
Sleep Disorder: 1 person, 3.57%
Petit Mal Epilepsy (absence seizure): 1 person, 3.57%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal and have Vasculitis?

- Check whether Vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Risperdal:

Risperdal (127,729 reports)

Vasculitis treatments and more:

Vasculitis (18,555 reports)

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis:

Vasculitis (968 drugs)

Browse all the conditions that are associated with Vasculitis:

Vasculitis (1,214 conditions)

Related publications that referenced our studies

Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperdal) and Risperdal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.